Peptide of the Week: GLOW and KLOW — 10% Off This Week
Peptide of the Week: GLOW and KLOW — 10% Off This Week
Tesamorelin is a synthetic, 44-amino acid peptide that acts as an analogue of the naturally occurring Growth Hormone-Releasing Hormone () [1, 2]. It is manufactured and developed by a Canadian company (Theratechnologies) and is highly studied worldwide for its selective and sustained ability to stimulate the body’s endogenous production of Growth Hormone () [4].
Its enhanced stability and unique pulsatile action make it a valuable tool for research models exploring metabolic disorders, body composition, neuroendocrine function, and the regulation of the / axis.
This 2025–2026 guide is strictly for scientific, laboratory, and in-vitro research.
Tesamorelin is structurally modified to be more stable and potent than native [2.1].
Tesamorelin is a full 44-amino acid sequence of human but features an modification (a trans-3-hexenoic acid group) [4]. This modification provides greater resistance to enzymatic degradation (specifically by dipeptidyl aminopeptidase) [6], resulting in:
Prolonged half-life: Sustained activity compared to native .
Enhanced bioavailability: Better pharmacological properties for in-vitro use.
Tesamorelin specifically binds to and stimulates the receptor on the somatotroph cells in the anterior pituitary gland [1]. This binding triggers a signaling cascade ( pathway), leading to:
Pulsatile Release: Tesamorelin stimulates the pituitary to release Growth Hormone () in a natural, pulsatile rhythm [1, 2].
Production: The released travels to the liver and other tissues, stimulating the production of Insulin-like Growth Factor 1 () [2].
Metabolic Effects: The resulting increase in and is studied for its effects on lipolysis (fat breakdown), protein synthesis, and metabolic regulation [3].
Tesamorelin is a key subject in studies exploring:
Metabolic and Lipid Homeostasis: Investigating its ability to selectively promote visceral adipose tissue () lipolysis and improve lipid profiles [2, 3].
Body Composition and Sarcopenia Models: Researching its role in increasing skeletal muscle density and lean muscle area alongside fat reduction [4].
Hepatic Research: Exploring its potential to decrease hepatic fat (liver fat) in models of Nonalcoholic Fatty Liver Disease () [4].
Neuroendocrine Studies: Investigating the modulation of and and their purported support of cognitive function and neuroplasticity [5].
Canadian labs expect:
✔ ≥99% purity (HPLC-verified)
✔ Batch-specific COA
✔ Mass spectrometry identity confirmation
✔ Uniform lyophilized cake
✔ Clear labeling and batch tracking
Purity is essential for accurate, reproducible in-vitro work.
A proper COA should include:
Inconsistent or generic COAs are major red flags.
Most domestic suppliers use:
Typical delivery time:
📦 1–2 business days Canada-wide
Why domestic shipping matters:
Research peptides benefit greatly from shorter transit times.
Canadian regulations allow Tesamorelin for:
✔ laboratory research
✔ biochemical assays
✔ molecular studies
✔ in-vitro experiments
✔ cell-based models
Not allowed:
❌ human use
❌ veterinary use
❌ dosing or administration instructions
❌ therapeutic claims
Research-use-only rules must always be followed.
Researchers avoid:
Transparency is mandatory for high-quality Canadian research suppliers.
Benefits include:
Domestic sourcing = more reliable scientific outcomes.
Yes — strictly for laboratory and in-vitro research.
No — only a legitimate research purpose.
No — it is not a therapeutic product.
Typically 1–2 business days within Canada.
Canadian labs typically expect ≥99% purity.
[2] Tesamorelin: A Review of its Structure, Mechanism of Action, and Therapeutic Potential. MDPI (2024).
[4] Tesamorelin Improves Fat Quality Independent of Changes in Fat Quantity. PubMed Central (2022).
[5] Tesamorelin: Uses, Interactions, Mechanism of Action. DrugBank Online (2016).
Peptides in the United States
https://luxaralabs.com/peptides-usa/
An overview for US-based researchers explaining how research peptides are sourced from Canada, including documentation standards, quality verification, and cross-border considerations.
US Peptide Research Regulations
https://luxaralabs.com/peptide-research-regulations-usa/
A clear explanation of how research peptides are treated under US regulatory frameworks, including FDA oversight, import screening, labeling requirements, and compliance considerations.
Shipping Peptides to the USA
https://luxaralabs.com/shipping-peptides-to-usa/
A transparent guide outlining what US researchers can expect when shipping peptides from Canada, including customs review, delivery timelines, and potential shipment outcomes.
All information is for scientific and laboratory reference only.
Tesamorelin is intended strictly for research, laboratory, and in-vitro use, not for human or animal use.
Tesamorelin is a stabilized synthetic analogue of Growth Hormone-Releasing Hormone (GHRH). Its primary mechanism involves stimulating the pituitary gland to release growth hormone (GH) in a natural, pulsatile manner. Unlike traditional GH therapy, Tesamorelin selectively activates hormone-sensitive lipase in abdominal adipose tissue, leading to a significant reduction in Visceral Adipose Tissue (VAT)—the dangerous fat surrounding organs—without affecting subcutaneous fat or BMI.
2026 research identifies Tesamorelin as a critical tool for studying MASLD (formerly NAFLD) and hepatic steatosis. By increasing GH and subsequently IGF-1 levels, the peptide facilitates the breakdown of liver triglycerides. Recent meta-analyses show that Tesamorelin can reduce hepatic fat percentage by a relative 40%, significantly improving liver enzyme markers like ALT and AST, making it a leading subject for research into metabolic-associated liver dysfunction.
While its primary fame is fat loss, Tesamorelin is highly anabolic for skeletal muscle quality. Research shows it significantly increases lean body mass (average gain of 1.42 kg) and improves muscle density (measured in Hounsfield Units). It is unique because it simultaneously reduces intramuscular fat (myosteatosis) while increasing the cross-sectional area of trunk muscles, making it a superior model for studying “Sarcopenic Obesity”.
Tesamorelin features an N-terminal modification with a trans-3-hexenoic acid group, providing greater resistance to enzymatic degradation than natural GHRH. For long-term preservation, the lyophilized powder must be stored desiccated at -20°C. Once reconstituted with sterile water, the solution is highly fragile; it should be used immediately or within a very narrow window. Do not shake the vial during reconstitution; instead, roll it gently for 30 seconds to avoid mechanical shearing of the 44-amino acid chain.
Precision in metabolic research requires absolute purity to avoid “glucose perturbation” or excessive fluid retention. Luxara Labs ensures every batch of Tesamorelin undergoes 3rd-party HPLC and MS testing to verify 99% purity. We provide expedited, temperature-stable shipping across Canada and the USA, ensuring that whether you are in Ontario, BC, or California, your materials arrive with their molecular identity and pituitary-stimulating potency fully intact.
Join our list and get an instant 10% discount code — valid for first-time buyers.
